Brief: Clover Biopharmaceuticals Says Completes BLA Submission For Seasonal Influenza Vaccine In Brazil
07/11/2023 24:42
Nov 7 (Reuters) - Clover Biopharmaceuticals 2197.HK :
* COMPLETES BLA SUBMISSION FOR SEASONAL INFLUENZA VACCINE IN
BRAZIL
* UPON BIOLOGIC LICENSE APPLICATION APPROVAL, WILL WORK WITH
LOCAL
PARTNER TO COMMERCIALIZE PRODUCT IN BRAZIL
Further company coverage: 2197.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clover Biopharmaceuticals
See all newsChina's Clover Biopharma H1 revenue drops sharply, flags going-concern doubt
Brief: Clover Biopharmaceuticals Posts FY Loss Of RMB205.1 MLN
Brief: Clover Announces Positive Phase I Clinical Data For Rsv-Hmpv-Piv3 Combination Vaccines And For Rsv Re-Vaccination In Older Adults
Brief: Clover Biopharmaceuticals Posts H1 Revenue Of RMB3.3 Million
Brief: Clover Biopharmaceuticals Says It Terminates Cooperation With Adimmune